chr3-73062575-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018029.4(EBLN2):āc.494C>Gā(p.Ala165Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018029.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EBLN2 | NM_018029.4 | c.494C>G | p.Ala165Gly | missense_variant | 1/1 | ENST00000533473.1 | NP_060499.3 | |
PPP4R2 | NM_174907.4 | c.420-1098C>G | intron_variant | ENST00000356692.10 | NP_777567.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EBLN2 | ENST00000533473.1 | c.494C>G | p.Ala165Gly | missense_variant | 1/1 | 6 | NM_018029.4 | ENSP00000432104.1 | ||
PPP4R2 | ENST00000356692.10 | c.420-1098C>G | intron_variant | 1 | NM_174907.4 | ENSP00000349124.5 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 1AN: 152222Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 249028Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135062
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461672Hom.: 0 Cov.: 63 AF XY: 0.00000275 AC XY: 2AN XY: 727120
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2024 | The c.494C>G (p.A165G) alteration is located in exon 1 (coding exon 1) of the EBLN2 gene. This alteration results from a C to G substitution at nucleotide position 494, causing the alanine (A) at amino acid position 165 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at